The global Biotechnology & Pharmaceutical Services Outsourcing market size is expected to be worth around US$ 105.4 billion by 2030, according to a new report by Vision Research Reports.
The global Biotechnology & Pharmaceutical Services Outsourcing market size was valued at US$ 63.1 billion in 2020 and is anticipated to grow at a CAGR of 6.8% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 5.78 billion by 2030 |
Growth Rate | CAGR of 6.1% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Service, End-use |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | The Quantic Group; IQVIA; Parexel International Corporation; Lachman Consultant Services, Inc.; GMP Pharmaceuticals Pty Ltd.; Concept Heidelberg GmbH; Covance, Inc.; Charles River Laboratories; PRA Health Sciences; ICON plc |
Growth Factors
Rising pricing pressure, lack of internal capabilities, low-cost service offerings by CROs and CMOs, and access to industry experts are expected to drive the market over the forecast period. In addition, rising drug development costs, higher failure rates, and growing regulatory pressure have a significant impact on market dynamics, accelerating the growth rate. Furthermore, well-established Clinical Research Organizations (CROs), regulatory outsourcing firms, management consulting firms, and contract manufacturers are catering to the complex demand of the pharmaceutical and biotechnological sectors.
An increasing number of end-to-end service providers to meet the rising demand for low-cost drug development and manufacturing is further anticipated to propel the growth of the market. Moreover, novel drug delivery mechanisms and new product launches are anticipated to drive the outsourcing demand.
By Service Analysis
Consulting services held the largest revenue share of over 16.0% in 2020. This can be attributed to the increasing M&A activities and constantly changing regulatory protocols.
The pharma and biotech market has witnessed the continuous entry of new players such as Signa Medical Writing; bioSyntagma; and Fieve Clinical Research, Inc. These players need to be compliant with set standards and norms, for which consulting is essential as these new entrants lack in such capabilities.
The other services segment is expected to expand at the highest CAGR over the forecast period owing to rising outsourcing of generics and biosimilar manufacturing as CMOs are offering services at a lower cost. The others segment is inclusive of contract manufacturing, product upgrade, and IT consulting.
By End-use Analysis
The pharma segment held the largest revenue share of over 55.0% in 2020 and is expected to maintain its lead throughout the forecast period. The segment is also expected to witness the fastest growth over the forecast period.
Lack of resources has prompted many pharmaceutical companies to outsource drug development and manufacturing of their products to CROs and CMOS. The CROs and CMOs offer highly sophisticated development and manufacturing services, such as preclinical development, clinical development, commercial manufacturing, clinical manufacturing.
By Regional Analysis
North America dominated the market with a revenue share of over 51.0% in 2020 owing to the presence of several established CROs and CMOs such as Covance Inc.; IQVIA; Catalent; and Samsung Biologics and growing R&D investments by life sciences and pharmaceutical companies in the region.
Asia Pacific is anticipated to witness the highest growth over the forecast period. Low cost of drug development and manufacturing and availability of skilled workforce is likely to foster contract development and manufacturing in this region.
Key Players
The Quantic Group
IQVIA
Parexel International Corporation
Lachman Consultant Services, Inc.
GMP Pharmaceuticals Pty Ltd.
Concept Heidelberg GmbH
Covance Inc.
Charles River Laboratories
PRA Health Sciences
ICON plc
Market Segmentation
By Service
Consulting
Regulatory Compliance
Remediation
Quality Management Systems Consulting
Others
Auditing and Assessment
Regulatory Affairs
Clinical Trial Applications & Product Registration
Regulatory Writing & Publishing
Legal Representation
Others
Product Maintenance
Product Design & Development
Product Testing & Validation
Training & Education
Others
By End-use
Pharma
Biotech
Regional
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
India
China
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
The Biotechnology & Pharmaceutical Services Outsourcing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Biotechnology & Pharmaceutical Services Outsourcing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Biotechnology & Pharmaceutical Services Outsourcing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biotechnology & Pharmaceutical Services Outsourcing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Biotechnology & Pharmaceutical Services Outsourcing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Biotechnology & Pharmaceutical Services Outsourcing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Biotechnology & Pharmaceutical Services Outsourcing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Biotechnology & Pharmaceutical Services Outsourcing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Biotechnology & Pharmaceutical Services Outsourcing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Biotechnology & Pharmaceutical Services Outsourcing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Biotechnology & Pharmaceutical Services Outsourcing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Biotechnology & Pharmaceutical Services Outsourcing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Biotechnology & Pharmaceutical Services Outsourcing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Biotechnology & Pharmaceutical Services Outsourcing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Biotechnology & Pharmaceutical Services Outsourcing market. These factors have benefited the growth of the global market for Biotechnology & Pharmaceutical Services Outsourcing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Biotechnology & Pharmaceutical Services Outsourcing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Biotechnology & Pharmaceutical Services Outsourcing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and End-use Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biotechnology & Pharmaceutical Services Outsourcing Market, By Service
7.1. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service, 2021-2030
7.1.1. Consulting
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Auditing and Assessment
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Regulatory Affairs
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Product Maintenance
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Product Design & Development
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Product Testing & Validation
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Training & Education
7.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Biotechnology & Pharmaceutical Services Outsourcing Market, By End-use
8.1. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-use, 2021-2030
8.1.1. Pharma
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Biotech
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Biotechnology & Pharmaceutical Services Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 10. Company Profiles
10.1. The Quantic Group
10.1.1. Company Overview
10.1.2. Service Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. IQVIA
10.2.1. Company Overview
10.2.2. Service Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Parexel International Corporation
10.3.1. Company Overview
10.3.2. Service Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Lachman Consultant Services, Inc.
10.4.1. Company Overview
10.4.2. Service Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. GMP Pharmaceuticals Pty Ltd.
10.5.1. Company Overview
10.5.2. Service Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Concept Heidelberg GmbH
10.6.1. Company Overview
10.6.2. Service Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Covance Inc.
10.7.1. Company Overview
10.7.2. Service Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Richard Wolf GmbH
10.8.1. Company Overview
10.8.2. Service Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Charles River Laboratories
10.9.1. Company Overview
10.9.2. Service Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. PRA Health Sciences
10.10.1. Company Overview
10.10.2. Service Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms